Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Equity Average: 2011-2025

Historic Equity Average for Rockwell Medical (RMTI) over the last 15 years, with Sep 2025 value amounting to $33.7 million.

  • Rockwell Medical's Equity Average rose 28.11% to $33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.7 million, marking a year-over-year increase of 28.11%. This contributed to the annual value of $26.9 million for FY2024, which is 52.21% up from last year.
  • Rockwell Medical's Equity Average amounted to $33.7 million in Q3 2025, which was up 8.88% from $31.0 million recorded in Q2 2025.
  • Rockwell Medical's Equity Average's 5-year high stood at $33.7 million during Q3 2025, with a 5-year trough of -$1.1 million in Q1 2022.
  • In the last 3 years, Rockwell Medical's Equity Average had a median value of $22.1 million in 2024 and averaged $23.5 million.
  • Per our database at Business Quant, Rockwell Medical's Equity Average tumbled by 103.76% in 2022 and then spiked by 1,272.89% in 2023.
  • Over the past 5 years, Rockwell Medical's Equity Average (Quarterly) stood at $6.8 million in 2021, then surged by 121.80% to $15.1 million in 2022, then skyrocketed by 41.55% to $21.4 million in 2023, then spiked by 44.18% to $30.9 million in 2024, then increased by 28.11% to $33.7 million in 2025.
  • Its last three reported values are $33.7 million in Q3 2025, $31.0 million for Q2 2025, and $32.1 million during Q1 2025.